Janiczek Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $626K | Buy |
41,055
+10,170
| +33% | +$155K | 0.13% | 67 |
|
|
2024
Q1 | $453K | Buy |
30,885
+8,700
| +39% | +$128K | 0.1% | 92 |
|
|
2023
Q4 | $309K | Buy |
22,185
+3,425
| +18% | +$47.7K | 0.07% | 109 |
|
|
2023
Q3 | $251K | Buy |
18,760
+1,800
| +11% | +$24.1K | 0.07% | 123 |
|
|
2023
Q2 | $214K | Buy |
16,960
+1,650
| +11% | +$20.8K | 0.06% | 124 |
|
|
2023
Q1 | $184K | Buy |
15,310
+1,320
| +9% | +$15.9K | 0.05% | 124 |
|
|
2022
Q4 | $149K | Buy |
13,990
+1,010
| +8% | +$10.8K | 0.04% | 160 |
|
|
2022
Q3 | $136K | Buy |
12,980
+4,400
| +51% | +$46.1K | 0.04% | 148 |
|
|
2022
Q2 | $88K | Sell |
8,580
-1,705
| -17% | -$17.5K | 0.03% | 217 |
|
|
2022
Q1 | $115K | Buy |
10,285
+5,065
| +97% | +$56.6K | 0.03% | 187 |
|
|
2021
Q4 | $68K | Buy |
5,220
+1,585
| +44% | +$20.6K | 0.02% | 258 |
|
|
2021
Q3 | $47K | Sell |
3,635
-595
| -14% | -$7.69K | 0.02% | 296 |
|
|
2021
Q2 | $62K | Buy |
4,230
+1,035
| +32% | +$15.2K | 0.02% | 216 |
|
|
2021
Q1 | $39K | Buy |
3,195
+1,140
| +55% | +$13.9K | 0.02% | 276 |
|
|
2020
Q4 | $29K | Buy |
2,055
+1,335
| +185% | +$18.8K | 0.01% | 288 |
|
|
2020
Q3 | $10K | Buy |
+720
| New | +$10K | 0.01% | 242 |
|